Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy-Reference-Cited by-同舟云学术

Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy

Published:2020 Issue:1 Volume:75 Page:29
ISSN:1598-9992
Container-title:The Korean Journal of Gastroenterology
language:en
Short-container-title:Korean J Gastroenterol

Author:

Kim Jihye¹²,Im Jong Pil¹^ORCID,Yim Jae-Joon³,Lee Chang Kyun⁴,Park Dong Il⁵,Eun Chang Soo⁶,Jung Sung-Ae⁷,Shin Jeong Eun⁸,Lee Kang-Moon⁹,Cheon Jae Hee¹⁰

Affiliation:

1. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.

3. Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Korea.

4. Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.

5. Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.

6. Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

7. Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

8. Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.

9. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

10. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Publisher

The Korean Society of Gastroenterology

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.4166/kjg.2020.75.1.29

Reference40 articles.

1. Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics

2. Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease

3. Immunological pathogenesis of inflammatory bowel disease

4. Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease

5. Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review;Clinical Microbiology and Infection;2024-08

2. THE EXPRESSION OF IFN - Γ, IL-10, IL-12 AND CCL1 IN PATIENTS WITH PULMONARY TUBERCULOSIS;ACTA MEDICA MEDITERR;2021

3. An Unexpected Cause of Headache and Splenic Lesions During Anti-TNF Therapy in Crohn Disease;Inflammatory Bowel Diseases;2020-08-19